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SCIENTIFIC OPINION 
Scientific Opinion on an application (EFSA-GMO-NL-2010-80) for the 
placing on the market of herbicide-tolerant genetically modified maize 
NK603 × T25 for food and feed uses, import and processing under 
Regulation (EC) No 1829/2003 from Monsanto
1
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2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Single events NK603 and T25 were combined to produce the stack two-event maize NK603 × T25. The EFSA 
GMO Panel previously assessed the two single events and did not identify safety concerns in the context of their 
scope. No new data on single maize events leading to a modification of the original conclusions on their safety 
were identified. Agronomic and phenotypic characteristics, as well as compositional data of maize 
NK603 × T25, did not give rise to food/feed and environmental safety concerns. The EFSA GMO Panel 
considers that there is no reason to expect interactions between the single events that could impact on the food 
and feed safety and the nutritional properties of maize NK603 × T25. There are no indications of an increased 
likelihood of establishment and spread of feral maize plants. Considering the scope of application EFSA-GMO-
NL-2010-80, potential interactions with the biotic and abiotic environment were not considered to be a relevant 
issue. The unlikely but theoretically possible transfer of the recombinant genes from maize NK603 × T25 to 
environmental bacteria does not give rise to any safety concern. The post-market environmental monitoring plan 
and reporting intervals are in line with the scope. In conclusion, the EFSA GMO Panel considers that the 
information available for maize NK603 × T25 addresses the scientific comments raised by Member States and 
that maize NK603 × T25, as described in this application, is as safe as its non-GM comparator and non-GM 
conventional maize varieties with respect to potential effects on human and animal health and the environment in 
the context of its scope. 
© European Food Safety Authority, 2015 
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SUMMARY 
Following the submission of application EFSA-GMO-NL-2010-80 under Regulation (EC) 
No 1829/2003 from Monsanto, the Panel on Genetically Modified Organisms of the European Food 
Safety Authority (EFSA GMO Panel) was asked to deliver a scientific opinion on the safety of 
herbicide-tolerant genetically modified (GM) maize NK603 × T25 (Unique Identifier MONØØ6Ø3-
6 × ACS-ZMØØ3-2). The scope of application EFSA-GMO-NL-2010-80 is for food and feed uses, 
import and processing, but excludes cultivation within the European Union (EU). 
The single maize events NK603 (expressing CP4 EPSPS) and T25 (expressing PAT) were assessed 
previously and no concerns were identified for human and animal health or environmental safety. No 
safety issue has been identified by updated bioinformatic analyses, or reported by the applicant, 
concerning the two single events since the publication of those scientific opinions. Consequently, the 
EFSA GMO Panel considers that its previous conclusions on the safety of the single maize events 
remain valid. 
The two-event stack maize NK603 × T25 was produced by conventional crossing to produce maize 
tolerant to glyphosate- and glufosinate-ammonium-based herbicides. The EFSA GMO Panel evaluated 
maize NK603 × T25 with reference to the scope and appropriate principles described in its guidelines 
for the risk assessment of genetically modified (GM) plants and derived food and feed, the 
environmental risk assessment of GM plants and the post-market environmental monitoring of GM 
plants. The scientific evaluation of the risk assessment included molecular characterisation of the 
inserted DNA and analysis of the expression of the corresponding proteins. An evaluation of the 
comparative analyses of the compositional, agronomic and phenotypic characteristics was undertaken, 
and the safety of the newly expressed proteins and of the whole food/feed was evaluated with respect 
to potential toxicity, allergenicity and nutritional wholesomeness. An evaluation of environmental 
impacts and the post-market environmental monitoring plan was also undertaken. In accordance with 
the EFSA GMO Panel guidance documents applicable to this application (EFSA, 2006, 2007), “Where 
all single events have been assessed, the risk assessment of stacked events should focus mainly on 
issues related to a) stability, b) expression of the events and c) potential interactions between the 
events”. Additional information received after May 2011 was assessed according to 2011 guidance 
(EFSA GMO Panel, 2011a). 
The molecular data establish that the transformation events stacked in maize NK603 × T25 have the 
same molecular properties and characteristics as the single transformation events. Comparison of the 
levels of the CP4 EPSPS and PAT proteins between the stack and the corresponding single events did 
not reveal an interaction that manifests at protein or trait expression level. From the molecular 
characterisation, no indications of interactions between the events based on the biological functions of 
the newly expressed proteins were identified. 
Based on the agronomic and phenotypic characteristics of maize NK603 × T25 under the tested 
conditions (not treated with the intended herbicide), some differences were observed in maize 
NK603 × T25 compared with its conventional counterpart. None of the significant differences 
observed needed further assessment for its potential environmental impact. Similarly, the EFSA GMO 
Panel concluded that none of the differences identified in the agronomic and phenotypic 
characteristics and in the composition of grain and forage obtained from maize NK603 × T25 needed 
further assessment regarding food and feed safety. 
The safety assessment identified no concerns regarding the potential toxicity of the newly expressed 
proteins CP4 EPSPS and PAT in maize NK603 × T25. The EFSA GMO Panel found no reason to 
suggest that the presence of the two proteins in combination would result in interactions producing 
effects different from those of the individual proteins. Similarly, no indications of safety concerns 
were identified regarding allergenicity of the individual newly expressed proteins or their mixture in 
maize NK603 × T25, or regarding potential changes in its overall allergenicity. Maize NK603 × T25 is 
as nutritious as non-GM conventional maize varieties. 
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Considering the scope of application EFSA-GMO-NL-2010-80, there is no requirement for scientific 
information on possible environmental effects associated with the cultivation of maize NK603 × T25 
in Europe. There are no indications of an increased likelihood of establishment and spread of feral 
maize NK603 × T25 plants in the event of accidental release into the environment of viable GM maize 
seeds. Potential interactions of maize NK603 × T25 with the biotic and abiotic environment were not 
considered to be a relevant issue by the EFSA GMO Panel. The unlikely but theoretically possible 
transfer of the recombinant genes from maize NK603 × T25 to environmental bacteria does not give 
rise to safety concerns owing to the lack of a selective advantage in the context of the scope of this 
application. The post-market environmental monitoring plan provided by the applicant and the 
reporting intervals are in line with the scope of application EFSA-GMO- NL-2010-80. 
In delivering its scientific opinion, the EFSA GMO Panel took into account application EFSA-GMO- 
NL-2010-80, additional information provided by the applicant, scientific comments submitted by the 
Member States and relevant scientific publications. In conclusion, the EFSA GMO Panel is of the 
opinion that the two-event stack maize NK603 × T25, as described in this application, is as safe as its 
non-GM comparator and non-GM conventional maize varieties with respect to potential effects on 
human and animal health and the environment in the context of its scope. 
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BACKGROUND 
On 21 May 2010, the European Food Safety Authority (EFSA) received from the Competent 
Authority of the Netherlands application EFSA-GMO-NL-2010-80, for authorisation of genetically 
modified (GM) maize NK603 × T25 submitted by Monsanto within the framework of Regulation (EC) 
No 1829/2003
4
 for food and feed uses, import and processing. 
After receiving the application EFSA-GMO-NL-2010-80 and in accordance with Articles 5(2)(b) and 
17(2)(b) of Regulation (EC) No 1829/2003, EFSA informed Member States and the European 
Commission, and made the summary of the application available to the public on the EFSA website.5 
EFSA initiated a formal review of the application to check compliance with the requirements laid 
down in Articles 5(3) and 17(3) of Regulation (EC) No 1829/2003. On 22 September 2010 EFSA 
received additional information (requested on 2 July 2010). On 12 October 2010, EFSA declared the 
application valid in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003. 
EFSA made the valid application available to Member States and the European Commission, and 
consulted nominated risk assessment bodies of Member States, including national Competent 
Authorities within the meaning of Directive 2001/18/EC
6
 following the requirements of Articles 6(4) 
and 18(4) of Regulation (EC) No 1829/2003 to request their scientific opinion. Member States had 
three months after the date of receipt of the valid application to make their opinion known. 
The EFSA GMO Panel carried out an evaluation of the scientific risk assessment of maize 
NK603 × T25 for food and feed uses, import and processing in accordance with Articles 6(6) and 
18(6) of Regulation (EC) No 1829/2003. The EFSA GMO Panel took into account the appropriate 
principles described in its guidelines for the risk assessment of GM plants and derived food and feed 
(EFSA, 2006), the environmental risk assessment of GM plants (EFSA GMO Panel, 2010) and on the 
post-market environmental monitoring of GM plants (EFSA GMO Panel, 2011b). Furthermore, the 
EFSA GMO Panel also took into consideration the scientific comments of Member States, the 
additional information provided by the applicant and relevant scientific publications. 
On 16 December 2013, 8 July 2014, 28 November 2014, 16 February 2015 and 19 March 2015 the 
EFSA GMO Panel requested additional information from the applicant. The applicant provided the 
requested information on 3 February 2014, 9 September 2014, 13 January 2015, 13 May 2015, 19 May 
2015 and on 27 May 2015. 
In giving its scientific opinion to the European Commission, the Member States and the applicant, and 
in accordance with Articles 6(1) and 18(1) of Regulation (EC) No 1829/2003, EFSA has endeavoured 
to respect a time limit of six months from the acknowledgement of the valid application. As additional 
information was requested by the EFSA GMO Panel, the time limit of six months was extended 
accordingly, in line with Articles 6(1), 6(2), 18(1), and 18(2) of Regulation (EC) No 1829/2003. 
According to Regulation (EC) No 1829/2003, this scientific opinion is to be seen as the report 
requested under Articles 6(6) and 18(6) of that Regulation and thus will be part of the EFSA overall 
opinion in accordance with Articles 6(5) and 18(5). 
TERMS OF REFERENCE 
The EFSA GMO Panel was requested to carry out a scientific assessment of maize NK603 × T25 for 
food and feed uses, import and processing in accordance with Articles 6(6) and 18(6) of Regulation 
(EC) No 1829/2003. 
                                                     
4 Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically 
modified food and feed. OJ L 268, 18.10.2003, p. 1–23. 
5 Available online: http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2010-00880.  
6 Directive 2001/18/EC of the European Parliament and of the Council of 12 March 2001 on the deliberate release into the 
environment of genetically modified organisms and repealing Council Directive 90/220/EEC. OJ L 106, 12.3.2001, p. 1–38. 
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Where applicable, any conditions or restrictions which should be imposed on the placing on the 
market and/or specific conditions or restrictions for use and handling, including post-market 
monitoring requirements based on the outcome of the risk assessment and, in the case of GMOs or 
food/feed containing or consisting of GMOs, conditions for the protection of particular 
ecosystems/environment and/or geographical areas should be indicated in accordance with Articles 
6(5)(e) and 18(5)(e) of Regulation (EC) No 1829/2003. 
The EFSA GMO Panel was not requested to give an opinion on information required under Annex II 
to the Cartagena Protocol. Furthermore, the EFSA GMO Panel did not consider proposals for labelling 
and methods of detection (including sampling and the identification of the specific transformation 
event in the food/feed and/or food/feed produced from it), which are matters related to risk 
management.  
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ASSESSMENT 
1. Introduction 
Application EFSA-GMO-NL-2010-80 covers a two-event stack maize produced by conventional 
crossing. The scope of this application is for food and feed uses, import and processing, but excludes 
cultivation in the European Union (EU). 
European Food Safety Authority (EFSA) guidance applicable to this application establishes that 
“Where all single events have been assessed, the risk assessment of stacked events should focus mainly 
on issues related to a) stability, b) expression of the events and c) potential interactions between the 
events” (EFSA, 2006, 2007). Additional information received after May 2011 was assessed in 
accordance with 2011 guidance (EFSA GMO Panel, 2011a). 
Maize NK603 × T25 was developed to confer tolerance to glyphosate (N-(phosphonomethyl)glycine)- 
and glufosinate-ammonium-based herbicides. Tolerance to glyphosate is achieved by expression of the 
CP4 5-enolpyruvylshikimate-3-phosphate synthase (CP4 EPSPS and CP4 EPSPS l214p—a variant of 
EPSPS with one amino acid substitution of proline for leucine at amino acid position 214). Tolerance 
to glufosinate-ammonium is achieved by the expression of the phosphinothricin acetyl transferase 
(PAT) protein. 
The two single maize events NK603 and T25 have been previously assessed (see Table 1) on the basis 
of experimental data. No concerns for human and animal health or environmental safety were 
identified. 
Table 1:  Single maize events already assessed by the EFSA Panel on Genetically Modified 
Organisms (GMO Panel) 
Event Application or mandate EFSA Scientific Opinion 
NK603 CE/ES/00/01 
Article 4 of the Novel Food Regulation 
(EC) No 258/97 
EFSA (2003a) 
EFSA (2003b) 
EFSA-GMO-NL-2005-22 
EFSA-GMO-RX-NK603 
EFSA (2009a) 
T25 EFSA-GMO-NL-2007-46 
EFSA-GMO-RX-T25 
EFSA GMO Panel (2013) 
2. Issues raised by Member States 
Issues raised by Member States on maize NK603 × T25 were considered in this scientific opinion and 
were addressed in detail in Annex G of the EFSA overall opinion.
7
 
3. Updated information on single events 
Since the publication of the scientific opinions on the single maize events by the EFSA GMO Panel 
(EFSA, 2003a, b, 2009a; EFSA GMO Panel, 2013), no safety issue pertaining to the two single events 
has been reported by the applicant. 
Updated bioinformatic analyses on the junction regions for events NK603 and T25 confirmed that no 
known endogenous genes were disrupted by any of the inserts.
8
 Updated bioinformatic analyses of the 
amino acid sequences of the newly expressed proteins and other open reading frames (ORFs) present 
within the insert and spanning the junction sites revealed no significant similarities to known toxins.
9
 
An updated search for similarity to allergens was performed using the criterion of 35 % identity of the 
                                                     
7 http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2015-00391 
8 Additional information: 19/5/2015. 
9 Additional information: 19/5/2015. 
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amino acid sequence of the newly expressed proteins and other ORFs to the amino acid sequence of 
known allergens in a window of 80 amino acids. Results did not indicate similarities of the newly 
expressed proteins with known allergens. Identity of over 35 % was found with ragweed (Ambrosia 
artemisiifolia) homologues of the Art v 1 allergen for an ORF within the NK603 insert. The putative 
translation product of this ORF would be generated from the reverse strand of the CP4 epsps 
transcriptional units. Considering that this ORF is not in the codon frame intended to be expressed, 
does not have known promoters upstream and in close proximity and does not include an ATG start 
codon at the N-terminal of the putative translation product, the likelihood that it is both transcribed 
and translated in maize NK603 × T25 is negligible. 
Having assessed the updated information on maize NK603 × T25, the EFSA GMO Panel considers 
that its previous conclusions on the safety of the single maize events remain valid. 
4. Risk assessment of the two-event stack maize NK603 × T25 
4.1. Molecular characterisation 
Possible interactions between the known biological functions conferred by the individual inserts and 
interactions that would manifest at protein expression level are considered. 
4.1.1. Genetic elements and their biological functions 
Maize NK603 and T25 are combined by conventional crossing to produce maize NK603 × T25. The 
structure of the inserts introduced into maize NK603 × T25 are described in detail in the EFSA GMO 
Panel scientific opinions, and no new genetic modifications were involved. Genetic elements in the 
expression cassettes of the single events are summarised in Table 2. 
Table 2:  Genetic elements in the expression cassettes of the events stacked in maize NK603 × T25 
Event Promoter 5 Leader Transit peptide Coding region Terminator 
NK603 P-Ract1 
(Oryza sativa) 
I-Ract1 
(O. sativa) 
TS-CTP2 
(Arabidopsis 
thaliana) 
CP4 epsps 
(Agrobacterium sp.) 
nos 
(Agrobacterium 
tumefaciens) 
P-e35S 
(CaMV) 
I-Hsp70 
(Zea mays) 
TS-CTP2 
(Arabidopsis 
thaliana) 
CP4 epsps l214p 
(Agrobacterium sp.) 
nos 
(Agrobacterium 
tumefaciens) 
T25
(a)
 35S 
(CaMV) 
– – pat 
(Streptomyces 
viridochromogenes) 
35S 
(CaMV) 
(a): The insert also contains the following elements: 616 bp of the pUC18 cloning vector including 5 bp of the bla gene at 
the 5′ of the expression cassette; and 1 841 bp of the pUC18 plasmid including a 665-bp 3′ fragment of the bla gene and 
the ori, and 346 bp of the 35S promoter at the 3′ end of the expression cassette. The remainder of the bla gene (about 
25 %) is not present in the insert. 
–, no element was specifically introduced to optimise expression. 
There are two newly expressed proteins
10
 in maize NK603 × T25, both of which are enzymes. 
Biological functions conferred by these proteins are summarised in Table 3. 
  
                                                     
10 CP4 EPSP and PAT including the variant CP4 EPSP l214p. 
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Table 3:  Biological functions of the events stacked in maize NK603 × T25 
Event Protein Function in donor organism Function in GM plant 
NK603 CP4 EPSPS and 
CP4 EPSPS L214P 
Donor organism: Agrobacterium 
sp. 
5-enopyruvyl-shikimate-3-
phosphate (EPSPS) synthase is an 
enzyme involved in the shikimic 
acid pathway for aromatic amino 
acid biosynthesis in plants and 
microorganisms (Herrmann, 1995) 
CP4 EPSPS L214P is a form of 
CP4 EPSPS that contains a single 
amino acid substitution from 
leucine to proline at position 214. 
Both CP4 EPSPS proteins confer 
tolerance to glyphosate (Funke et 
al., 2006; Garg et al., 2014) 
T25 PAT Donor organism: Streptomyces 
viridochromogenes 
Phosphinothricin-acetyl-transferase 
(PAT) enzyme confers resistance 
to the antibiotic bialaphos (Strauch 
et al., 1988) 
PAT acetylates L-glufosinate-
ammonium and thereby confers 
tolerance to glufosinate-
ammonium-based herbicides 
(Droge-Laser et al., 1994) 
4.1.2. Integrity of the events in maize NK603 × T25 
The genetic stability of the inserted DNA over multiple generations in the single maize events NK603 
and T25 was demonstrated previously (EFSA, 2003a, b, 2009a; EFSA GMO Panel, 2013). Integrity of 
the events in maize NK603 × T25 was demonstrated by Southern analyses
11
 in an F1 generation 
representative of commercial seed production. 
4.1.3. Information on the expression of the inserts12 
Plants were grown at five locations (three replicate blocks each) under field conditions in 2008 in the 
USA. The levels of CP4 EPSPS and PAT proteins in maize NK603 × T25 and the two single events 
were quantified by enzyme-linked immunosorbent assay (ELISA). Protein levels were determined in 
leaves and root (growth stages V2–V4), whole plant (V10–V12), pollen, forage root and forage (early 
dent) and grain (maturity). The plants were treated with the intended herbicides (glyphosate and/or 
glufosinate-ammonium). Data on grain and forage are reported and discussed below (Table 4). CP4 
EPSPS and PAT protein levels in the two-event stack maize were similar to the corresponding levels 
in the single-event maize plants. 
Table 4:  Means and standard deviations (upper row) and ranges (lower row) of protein levels (μg/g 
dry weight) in grain and forage from maize NK603 × T25 and from single maize events NK603 and 
T25 
 Protein NK603 × T25 NK603 T25 
Grain CP4 EPSPS 
(a)
 8.1 ± 1.1 
(6.2–10) 
7.2 ± 1.4 
(5.5–11) 
NA 
PAT 
0.59 ± 0.18 
(0.28–0.83) 
NA 0.43 ± 0.10 
(0.29–0.68) 
Forage 
CP4 EPSPS
(a)
 53 ± 17 
(25–96) 
50 ± 15 
(29–85) 
NA 
PAT 
14 ± 5.6 
(6.7–25) 
NA 14 ± 9.2 
(6.1–39) 
(a): The values given represent the sum of CP4 EPSPS and CP4 EPSPS L214P, as the ELISA analytical method recognises 
both these proteins expressed in NK603 × T25 and NK603. 
NA, not applicable. 
                                                     
11 Dossier: Part I—Section D2. 
12 Dossier: Part I—Section D3. 
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4.1.4. Conclusion 
The molecular data establish that the transformation events stacked in maize NK603 × T25 have the 
same molecular properties and characteristics as the single transformation events. Comparison of the 
levels of the CP4 EPSPS and PAT proteins between the stack and the single events did not reveal an 
interaction that manifests at protein expression level. The molecular characterisation revealed no 
indications of interactions between the events based on the biological functions of the newly expressed 
proteins. 
4.2. Comparative analysis 
4.2.1. Evaluation of relevant scientific data 
4.2.1.1. Choice of comparator and production of material for the comparative analysis13 
Field trials were performed in order to compare phenotypic and agronomic characteristics of maize 
NK603 × T25, its conventional counterpart (LH283  PSB327414) and 20 non-genetically modified 
(GM) maize commercial varieties, and to produce forage and grain material for compositional 
analyses. The conventional counterpart had a genetic background similar to maize NK603 × T25. The 
field trials were performed at five sites in North America (one each in Iowa and Kansas and three in 
Illinois) in 2008, all sites located in the major maize-growing regions of the USA. At each field trial 
site the maize materials were grown in a randomised complete block design with three replications and 
included maize NK603 × T25 sprayed with glyphosate and glufosinate-ammonium on top of 
maintenance pesticides
15
 (used for the compositional studies
16
), maize NK603 × T25 not treated with 
target herbicides on top of maintenance pesticides (used for the agronomic/phenotypic 
characterisation
17
), and the conventional counterpart and 4 of 20 non-GM maize commercial 
varieties
18
 sprayed with the same maintenance pesticides. The maintenance pesticides were chosen 
depending on the local requirements. The identities of the maize materials included in the field trials 
were confirmed using chain-of-custody records and by characterisation of the CP4 epsps and pat 
coding regions in their hereditary material by event-specific polymerase chain reaction (PCR) 
analysis. This analysis identified that one of the non-GM maize commercial varieties at one of the 
field trial sites in Illinois possibly contained adventitious presence of one of the studied GM events. 
This maize commercial variety (MG 8122) was omitted from the compositional analysis. 
4.2.1.2. Agronomic and phenotypic characteristics 
In the analyses of agronomic and phenotypic characteristics of maize NK603 × T25, its conventional 
counterpart and 20 non-GM maize commercial varieties (all maize materials given maintenance 
pesticides according to local requirements), 14 endpoints were studied.
19
 In addition to these 
agronomic and phenotypic characteristics, arthropod damage and plant response to abiotic stressors 
and disease damage were evaluated for their environmental interaction characteristics.  
Data on agronomic and phenotypic endpoints were statistically analysed for potential differences 
between maize NK603 × T25 and its conventional counterpart using two models based on analysis of 
variance (ANOVA): an across-site ANOVA (all trial sites combined) followed by an individual-site 
                                                     
13 Dossier: Part I—Sections A3.1–A3.2; additional information: 17/2/2014. 
14 The conventional counterpart was called TXN in some documents of the application. 
15 Additional information: 3/2/2014. 
16 The experimental design for the compositional analysis does not allow distinguishing the effects of the genetic 
modification from the herbicide treatments. 
17 The experimental design for the agronomic/phenotypic characterisation allows a direct comparison between the four-event 
stack maize and its conventional counterpart in the presence of maintenance herbicides. 
18 The non-GM maize reference varieties used in these studies were DKC63-78, RC772, DKC62-30, BT 6610, Burrus 645, 
Crows 5151, N76-H2, 33H25, 33M54, C 5303, MG 8122, NC+ 5411, MG 8403, Stewart S650, Stone M24, C 6501, 
RX910, 31P41, MG 87801 and FC 7864. 
19 Early stand count, final stand count, seedling vigour, days to 50 % silking, days to 50 % pollen shed, ear height, plant 
height, stay green, dropped ears, stalk lodging, root lodging, grain moisture, test weight and yield. 
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analysis. No statistical comparisons were made between maize NK603 × T25 and the set of non-GM 
maize commercial varieties.  
In the across-sites analysis, no significant differences were found between maize NK603 × T25 and 
the conventional counterpart for any of the 14 agronomic and phenotypic endpoints studied. Six 
statistically significant differences were observed in the individual site analyses. Four differences 
occurred at one field site whereas one difference was observed at two sites. 
Three abiotic stressors, three diseases and three arthropod pests were evaluated four times during the 
growing season at each field trial site. These ecological interactions were selected on the basis that 
they were either actively causing plant injury in the study area or likely to occur in maize during the 
study period. A difference in susceptibility or tolerance to abiotic stressors, diseases and arthropod 
pests on a particular observation time was declared significant if the range of injury or severity to 
maize NK603 × T25 did not overlap with the range of injury or severity to the conventional 
counterpart across all three replications. There was no difference in response to abiotic stress between 
maize NK603 × T25 and the conventional counterpart for 49 out of 50 individual site comparisons, 
and no difference in disease damage and arthropod damage for any of the 65 and 60 comparisons. The 
only difference observed between maize NK603 × T25 and the conventional counterpart was for hail 
damage during the first observation at one of the field trials in Illinois, where it was observed (slight) 
in maize NK603 × T25 and not in the conventional counterpart. 
4.2.1.3. Compositional analysis20 
Maize forage was harvested from field trials in the USA in 2008 and analysed for proximates (crude 
protein, crude fat, ash and moisture), carbohydrates by calculation, fibre fractions (acid detergent fibre 
(ADF), neutral detergent fibre (NDF)), calcium and phosphorus. Maize grain harvested from the same 
field trials was, in addition to proximates and fibre fractions (ADF, NDF and total dietary fibre), 
analysed for 18 amino acids,
21
 22 fatty acids,
22
 nine minerals,
23
 seven vitamins
24
 and five secondary 
metabolites and/or anti-nutrients (furfural, p-coumaric acid, ferulic acid, phytic acid and raffinose). In 
total, 69 different compounds were analysed in the grain material and nine in the forage material, in 
accordance with OECD (2002). Fifteen grain constituents that occurred at levels below the limit of 
quantification in more than 50 % of the samples were omitted from the statistical analysis.
25
 
For each endpoint, the potential differences in level between maize NK603 × T25 (sprayed with target 
herbicides) and its conventional counterpart (not sprayed with target herbicides) were investigated 
using two models: an across-site ANOVA (all trial sites combined) followed by an individual-site 
analysis. When a statistically significant difference was identified, the levels in maize NK603 × T25 
and the conventional counterpart were compared with those observed in non-GM maize commercial 
varieties, obtained both from analytical data on the varieties included in the field trials and from 
published data in the scientific literature. 
                                                     
20 Dossier: Part I—Section A3.3. 
21 Alanine, arginine, aspartic acid, cysteine, glutamic acid, glycine, histidine, isoleucine, leucine, lysine, methionine, 
phenylalanine, proline, serine, threonine, tryptophan, tyrosine and valine. 
22 Caprylic acid (C8:0), capric acid (C10:0), lauric acid (C12:0), myristic acid (C14:0), myristoleic acid (C14:1), 
pentadecanoic acid (C15:0), pentadecenoic acid (C15:1), palmitic acid (C16:0), palmitoleic acid (C16:1), heptadecanoic 
acid (C17:0), heptadecenoic acid (C17:1), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2), linolenic acid 
(C18:3), -linolenic acid (C18:3), arachidic acid (C20:0), eicosenoic acid (C20:1), eicosadienoic acid (C20:2), 
eicosatrienoic acid (C20:3), arachidonic acid (C20:4) and behenic acid (C22:0). 
23 Calcium, phosphorus, potassium, sodium, iron, copper, magnesium, manganese and zinc. 
24 Thiamine, riboflavin, niacin, pyridoxine, folic acid, β-carotene and vitamin E. 
25 The following constituents were excluded from the statistical analysis: caprylic acid (C8:0), capric acid (C10:0), lauric acid 
(C12:0), myristic acid (C14:0), myristoleic acid (C14:1), pentadecanoic acid (C15:0), pentadecenoic acid (C15:1), 
heptadecanoic acid (C17:0), heptadecenoic acid (C17:1), -linolenic acid (C18:3), eicosadienoic acid (C20:2), 
eicosatrienoic acid (C20:3), arachidonic acid (C20:4) and furfural. 
Scientific Opinion on GM maize NK603 × T25  
 
EFSA Journal 2015;13(7):4165 12 
In the across-site analysis, statistically significant differences between maize NK603 × T25 (sprayed 
with target herbicides) and its conventional counterpart (not sprayed with the target herbicides) were 
identified for 11 compositional endpoints, two in forage and nine in grain (Table 5).  
The two forage endpoints (moisture and crude protein) were well within the ranges of the non-GM 
commercial maize varieties. All the significant differences in grain compounds (Table 5) were within 
the range of the non-GM commercial maize varieties included in the study (except for palmitoleic acid 
and raffinose) or in the range reported in the literature (Watson, 1987; Autran et al., 2003; Herman et 
al., 2007), and were of small magnitude. Considering the known chemical and biological 
characteristics of the compounds concerned and the magnitudes of the changes observed, the EFSA 
GMO Panel did not identify a need to further consider any of these differences. 
Table 5:  Constituents occurring at different levels in forage and grain of maize NK603 × T25 and 
LH283 × PSB3274 (conventional counterpart) harvested from field trials in the USA in 2008. As a 
reference the range in the level of these constituents in non-GM maize commercial varieties grown in 
the same field trial is given 
Constituents (units) Means across locations (2008 field trials) 
Maize 
NK603 × T25 
(a)
 
Conventional 
counterpart 
(LH283 × PSB3274) 
(a)
 
Range of non-
GM maize 
variety values 
Forage 
Moisture (% of fresh weight) 70.21 ± 0.53 72.97 ± 0.53 67.40–76.30 
Crude protein (% dw) 7.37 ± 0.29 7.85 ± 0.29 4.77–8.45 
Grain 
(a)
 
Ash (% of dw) 1.60 ± 0.05 1.53 ± 0.05 1.14–1.70 
Potassium (% dw) 0.36 ± 0.008 0.35 ± 0.008 0.31–0.41 
Palmitic acid (C16:0) 
(b)
 9.48 ± 0.03 9.34 ± 0.03 9.13–13.42 
Palmitoleic acid (C16:1) 
(b)
 0.17 ± 0.003 0.16 ± 0.003 0.06–0.15 
Oleic acid (C18:1) 
(b)
 27.82 ± 0.62 28.24 ± 0.62 22.40–32.75 
Linolenic acid (C18:3) 
(b)
 0.94 ± 0.01 1.02 ± 0.01 0.85–1.30 
β-carotene (mg/kg dw) 1.03 ± 0.04 1.08 ± 0.04 0.72–1.73 
Thiamine (mg/kg dw) 3.28 ± 0.05 2.97 ± 0.05 2.76–4.56 
Raffinose (% dw) 0.18 ± 0.015 0.20 ± 0.015 0.09–0.17 
(a): Least-square mean ± standard error. 
(b): Fatty acid proportions are given as percentages of total fatty acid content. 
dw, dry weight. 
4.2.2. Conclusion 
Based on the agronomic and phenotypic characteristics of maize NK603 × T25 under the tested 
conditions (not treated with the intended herbicide), a difference was observed in maize NK603 × T25 
compared with its conventional counterpart. The difference observed for hail damage did not need 
further assessment for its potential environmental impact. 
The EFSA GMO Panel concluded that none of the differences identified in the agronomic and 
phenotypic characteristics and in the composition of grain and forage obtained from maize 
NK603 × T25 needed further assessment regarding food and feed safety. 
4.3. Food and feed safety assessment 
4.3.1. Effect of processing26 
Maize NK603 × T25 will undergo existing methods of production and processing used for commercial 
maize. No novel method of production and processing is envisaged. 
                                                     
26 Dossier: Part I—Section A3.5. 
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4.3.2. Toxicology 
4.3.2.1. Toxicological assessment of newly expressed proteins 
Two proteins (CP4 EPSPS
27
 and PAT) are newly expressed in maize NK603 × T25. The EFSA GMO 
Panel has previously assessed these proteins individually in the context of the single events (see 
Table 1), and no safety concern was identified. The EFSA GMO Panel is not aware of any new 
information that would change these conclusions.  
The two proteins are enzymes that catalyse distinctly different biochemical reactions and act on 
unrelated substrates. Consequently, the EFSA GMO Panel found no reason to suggest that the 
presence of the two proteins in combination would result in effects different from those of the 
individual proteins. As the individual proteins were considered safe for humans and animals (EFSA 
2009a; EFSA GMO Panel, 2013), the same conclusion can be extended to the combination. 
4.3.2.2. Toxicological assessment of components other than newly expressed proteins 
The two-event stack maize did not show any compositional difference from its conventional 
counterpart that would require further assessment (see Section 4.2). No further food and feed safety 
assessment of components other than newly expressed proteins is required. 
4.3.2.3. Animal studies with the food/feed derived from GM plants 
A 42-day feeding study with a total of 800 day-old male and female chickens for fattening (Cobb 500) 
was provided.
28
 The birds were randomly allocated to eight dietary treatments with 100 chickens per 
treatment (five pens/treatment per sex, initially 12 birds per pen and reduced to 10 birds per pen at 
day 7). Maize NK603 × T25 (verified by PCR), treated with the intended herbicide,
29
 was compared 
with its conventional counterpart and with six non-GM commercial varieties (NK N64Z, Burrus 645, 
Golden Harvest, Middlekoop 3210, Asgrow RX715, Garst 8424). The starter and grower/finisher diets 
contained about 60 % and 64 % maize,
30
 respectively. Other main components were soybean meal and 
corn gluten meal. Before feed formulation, grains of all maize varieties were analysed for proximates, 
amino acids, minerals and fatty acids, mycotoxins and pesticide residues. The diets were calculated to 
be isonitrogenous (confirmed by analysis) and isocaloric. The starter diets (about 22 % crude protein 
(CP), 3 080 kcal metabolisable energy (ME)/kg) were given until day 21, grower/finisher diets (about 
21 % CP, 3 100 kcal ME/kg) from day 8 to day 21, and finisher diets (about 20 % CP, 3 135 kcal 
ME/kg) from day 22 until the end. Feed (starter as crumbles and grower/finisher as pellets) and water 
were provided for ad libitum intake. 
Chickens were observed twice daily for clinical signs; deaths were recorded and necropsy performed 
on all birds found dead. Body weight per pen was measured at the start and the end. Feed intake was 
determined at day 21 and day 42. At days 43 (males) and 44 (female) all surviving birds were taken 
for carcass evaluation (dressing percentage, weight of thighs, breast, wings, drums, abdominal fat and 
whole liver). Data were statistically analysed by a two-factor ANOVA (diet and sex), and pair-wise 
comparison was made by Fischer’s Least Significant Difference test. A mixed linear model was 
applied to compare the maize NK603 × T25 group with the mean of all non-GM varieties. 
Overall mortality was low (< 3%) with no significant differences between the groups. No significant 
treatment × sex interaction was detected for performance characteristics. Overall, no significant 
difference was seen in final body weight (about 2.5 kg), feed intake (about 4.0 kg), or feed to gain 
ratio (about 1.61) between the maize NK603 × T25, the conventional counterpart or the non-GM 
commercial varieties. No significant differences were observed in carcass parameters (except that the 
                                                     
27 Including its variant CP4 EPSP l214p. 
28 Dossier: Part I— CQR-09-010 (2010 & 2010b); Additional information: 12/6/2012. 
29 Addition information: 13/5/2015. 
30 Maize materials are derived from field trial 2008. 
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fat content of the pad was lower for maize NK603 × T25 than for the conventional counterpart, but 
essentially similar to all non-GM commercial varieties). 
The study did not show unintended effects of maize NK603 × T25 at the inclusion level of 60 % in 
complete feed. The Panel concluded that maize NK603 × T25 is as nutritious as the conventional 
counterpart and six non-GM commercial varieties. 
4.3.3. Allergenicity 
For allergenicity assessment, a weight-of-evidence approach is followed, taking into account all of the 
information obtained on the newly expressed proteins, as no single piece of information or 
experimental method yields evidence to predict allergenicity (EFSA, 2006; Codex Alimentarius, 
2009). In addition, when known functional aspects of the newly expressed protein or structural 
similarity to known adjuvants may indicate an adjuvant activity, the possible role of these proteins as 
adjuvants is considered. When newly expressed proteins with a potential adjuvant activity are 
expressed together, possible interactions increasing adjuvanticity and impacting the allergenicity of the 
GM crop are assessed. 
4.3.3.1. Assessment of allergenicity of the newly expressed proteins31 
For allergenicity, the EFSA GMO Panel previously evaluated the safety of the CP4 EPSPS and PAT 
proteins, and no concerns about allergenicity were identified in the context of the applications assessed 
(see Table 1). No new information on allergenicity of the single events that might change the previous 
conclusions of the EFSA GMO Panel has become available. Based on current knowledge, and as none 
of the newly expressed proteins showed allergenicity, no reasons for concern regarding the mixture of 
these newly expressed proteins in this two-event stack maize in terms of allergenicity were identified. 
As regards adjuvanticity, no information available on the structure or function of the newly expressed 
CP4 EPSPS and PAT proteins would suggest an adjuvant effect of the individual proteins or their 
mixture in maize NK603 × T25 resulting in or increasing an eventual immunoglobulin E response to a 
bystander protein. 
4.3.3.2. Assessment of allergenicity of the whole GM plant32 
To date, maize has not been considered to be a common allergenic food
33
 (OECD, 2002), and 
therefore the EFSA GMO Panel did not request experimental data to analyse the allergen repertoire of 
GM maize. The EFSA GMO Panel regularly reviews the available publications on food allergy to 
maize (e.g. EFSA GMO Panel, 2013). 
In the context of the present application and considering the data from the molecular characterisation, 
the compositional analysis and the assessment of the newly expressed proteins, the EFSA GMO Panel 
identified no indications of safety concerns regarding the overall allergenicity of maize NK603 × T25. 
4.3.4. Nutritional assessment of GM food/feed 
The intended trait of maize NK603 × T25 is herbicide tolerance, with no intention of altering the 
nutritional parameters. Comparison of maize NK603 × T25 composition with that of its conventional 
counterpart did not identify differences that would require a safety assessment (see Section 4.2). From 
these data, the nutritional characteristics of maize NK603 × T25-derived food and feed are not 
expected to differ from those of conventional maize varieties. This was confirmed by the results of a 
feeding study in chickens for fattening (see Section 4.3.2.3). 
                                                     
31 Dossier: Part I—Section D7.9.1. 
32 Dossier: Part I—Section D7.9.2. 
33 Directive 2007/68/EC of the European Parliament and of the Council of 27 November 2007 amending Annex IIIa to 
Directive 2000/13/EC of the European Parliament and of the Council as regards certain food ingredients. OJ L 310, 
27.11.2007, p. 11–14. 
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4.3.5. Post-market monitoring of GM food/feed 
The EFSA GMO Panel considers that post-market monitoring of GM food/feed is not necessary, given 
the absence of safety concerns identified for maize NK603 × T25. 
4.3.6. Conclusion 
The safety assessment identified no concerns regarding the potential toxicity of the newly expressed 
proteins CP4 EPSPS and PAT in maize NK603 × T25. The EFSA GMO Panel found no reason to 
suggest that the presence of the two proteins in combination would result in interactions producing 
effects different from those of the individual proteins. Similarly, no indications of safety concerns 
were identified regarding allergenicity of the individual newly expressed proteins or their mixture in 
maize NK603 × T25, or regarding potential changes in its overall allergenicity. Maize NK603 × T25 is 
as nutritious as non-GM conventional maize varieties. 
4.4. Environmental risk assessment and monitoring plan 
4.4.1. Evaluation of relevant scientific data 
The scope of the application EFSA-GMO-NL-2010-80 is for food and feed uses, import and 
processing of maize NK603 × T25 expressing the CP4 EPSPS and PAT proteins for, respectively, 
glyphosate and glufosinate-ammonium herbicide resistance. The scope does not include cultivation
 
and, therefore, the environmental risk assessment (ERA) of maize NK603 × T25 is concerned with (1) 
the exposure of bacteria to recombinant DNA in the gastrointestinal tract of animals fed GM material 
and those present in environments exposed to faecal material (manure and faeces) and (2) the 
accidental release into the environment of viable seeds of maize NK603 × T25 during transport and/or 
processing. 
4.4.2. Environmental risk assessment 
4.4.2.1. Potential unintended effects on plant fitness due to the genetic modification34 
Fourteen agronomic and phenotypic characteristics as well as three abiotic stressors, three diseases and 
three arthropod pests were assessed on maize NK603 × T25 from field trials conducted in maize-
growing areas in North America (five locations: one each in Iowa and Kansas and three in Illinois) 
during the 2008 growing season, in a randomised complete block design with three replications (for 
more details, see Section 4.2.1). The results show that the agronomic performance and phenotypic 
characteristics of maize NK603 × T25 are similar to those of the conventional counterpart in the 
across-sites analyses. Six statistically significant differences were observed in the individual site 
analyses. Four differences occurred at one field site, whereas one difference was observed at two sites. 
The EFSA GMO Panel considers it likely that these small and inconsistent differences were incidental. 
There were no differences in response to abiotic stress between maize NK603 × T25 and the 
conventional counterpart for 49 out of 50 comparisons, and no difference in disease and arthropod 
damage for any of the 65 and 60 comparisons. Hail damage was recorded as “slight” (i.e. symptoms 
not damaging to plant development) in maize NK603 × T25, whereas there was “none” in the 
conventional counterpart in the first observation at one of the field trials in Illinois and this slight hail 
damage was within the range observed in the reference varieties. 
Based on the inserted traits, the EFSA GMO Panel considers that agronomic and phenotypic 
characteristics are unchanged in maize NK603 × T25. The EFSA GMO Panel concludes that there is 
very little likelihood that maize NK603 × T25 has any tendency towards increased persistence and 
invasiveness following accidental release into the environment of viable GM maize grains, as the 
presence of the intended herbicides would confer only a short-term selective advantage with no 
relevance to the development of longer term populations. 
                                                     
34 Dossier: Part I—Sections D9.1 and D9.2. 
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Maize is highly domesticated and generally unable to survive in the environment without management 
intervention. Maize plants are not winter hardy in many regions of Europe; furthermore, they have lost 
their ability to release grain from the cob and they do not occur outside cultivated land or disturbed 
habitats in agricultural landscapes of Europe, despite cultivation for many years. In cultivation, maize 
volunteers may arise under some environmental conditions (e.g. mild winters). Observations made on 
cobs, cob fragments or isolated grain shed in the field during harvesting indicate that grain may 
survive and overwinter in some regions, resulting in volunteers in subsequent crops. The occurrence of 
maize volunteers has been reported in Spain and other European regions (e.g. Gruber et al., 2008). 
However, maize volunteers have been shown to grow weakly and flower asynchronously with the 
maize crop (Palaudelmàs et al., 2009). 
Therefore, considering the scope of maize NK603 × T25, the outcomes of the molecular 
characterisation and the comparative analysis, and the poor ability of maize to survive outside 
cultivated land, the EFSA GMO Panel concludes that there are no indications that maize 
NK603 × T25 has increased fitness potential compared with its conventional counterpart. 
4.4.2.2. Potential for gene transfer 
A prerequisite for any gene transfer is the availability of pathways for the transfer of genetic material, 
either horizontal gene transfer of DNA or vertical gene flow via seed dispersal and cross-pollination. 
(a) Plant-to-bacteria gene transfer
35
 
Genomic plant DNA is a component of several food and feed products derived from maize. It is well 
documented that DNA present in food and feed becomes substantially degraded during processing and 
digestion in the human or animal gastrointestinal tract. However, a low level of exposure of fragments 
of ingested DNA, including the recombinant fraction of such DNA, to microorganisms, especially 
bacteria, in the digestive tract of humans, domesticated animals and other environments exposed to the 
GM plant or plant material is expected.  
Current scientific knowledge of recombination processes in bacteria suggests that horizontal gene 
transfer of non-mobile, chromosomally located DNA fragments between unrelated organisms (such as 
from plants to bacteria) is not expected to occur at detectable frequencies under natural conditions (for 
further details, see EFSA, 2009b).  
A successful horizontal gene transfer would require stable insertion of the recombinant DNA 
sequences into a bacterial genome and a selective advantage to be conferred on the transformed host. 
The only mechanism known to facilitate horizontal transfer of non-mobile, chromosomal DNA 
fragments to bacterial genomes is homologous recombination. In the case of sequence identity 
between the transgenic DNA and the natural variants of the gene in bacteria, recombination could 
result in a gene replacement in bacteria. In the case of two pairs of sequences with sufficient length of 
identity and correct orientation, recombination could facilitate the transfer of insert sequences to 
bacterial recipients by double homologous recombination.  
Maize NK603 × T25 contains several genetic elements of bacterial origin. These are (1) the coding 
sequence of the CP4 epsps gene from Agrobacterium sp. CP4; (2) the coding sequence of the pat gene 
from Streptomyces viridochromogenes; (3) two nopaline synthase (nos)-terminator sequences, each 
with a length of 300 bp, from the Ti plasmid of A. tumefaciens; (4) a sequence of 665 bp of the 3′ 
prime end of the β-lactamase gene as is present on plasmids of Escherichia coli; and (5) two 
sequences of 611 bp and 1 176 bp from the pUC cloning vector used in E. coli, the latter sequence 
including the origin of replication (ori). Bioinformatic analyses confirmed, except for the pat gene, 
high sequence identities between the above-mentioned sequences and the origin from which they were 
derived. Owing to codon optimisation, the pat gene showed insufficient sequence identity with 
bacterial sequences to facilitate homologous recombination. 
                                                     
35 Dossier: Part I—Section D6a. 
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Whereas E. coli is considered to be prevalent in the main receiving environment, i.e. the 
gastrointestinal tract of humans or animals, Agrobacterium species, including A. tumefaciens, or its 
close relatives from the genus Rhizobium, are not expected to be prevalent in the gastrointestinal tract. 
However, occurrence of the recombinant genes outside the immediate receiving environment (through 
faecal material), in habitats where E. coli would be less prevalent but where A. tumefaciens could be 
more abundant, cannot be ruled out (Hart et al., 2009) and is therefore also taken into account for 
assessing the risks associated with a horizontal gene transfer. 
On a theoretical basis (i.e. without any study providing experimental evidence for the occurrence of 
horizontal gene transfer in the case of GM food and feed derived from maize NK603 × T25 or any 
other GM plant), it can be assumed that, as an extremely rare event, homologous recombination may 
occur in the environment between nucleotide sequences of the recombinant CP4 epsps gene and their 
natural variants, as they may occur in A. tumefaciens CP4 or other strains.  
The nos-terminator sequences present in maize NK603 × T25 may facilitate double homologous 
recombination with the corresponding nos gene on Ti plasmids of environmental A. tumefaciens 
strains. Theoretically, such recombination could result in the acquisition of the CP4 epsps gene on 
natural Ti plasmids. Likewise, the plant codon-optimised pat gene could be transferred by double 
homologous recombination into pUC or pUC-related plasmids as they may occur in E. coli or other 
bacteria. Owing to the presence of an ori within the recombinant gene cassette, an independent 
plasmid could theoretically also be formed in receiving bacteria and have the capacity for autonomous 
replication in bacteria that recognise the ori. 
In addition to homology-based recombination processes, illegitimate recombination that does not 
require the presence of DNA similarity between the recombining DNA molecules is theoretically 
possible. However, the transformation rates for illegitimate recombination were considered to be 10
10
-
fold lower than those for homologous recombination (Hülter and Wackernagel, 2008; EFSA, 2009b). 
Illegitimate recombination events have not been detected in studies that have exposed bacteria to high 
concentrations of GM plant DNA (EFSA, 2009b). In comparison to the above-described homology-
facilitated recombination processes, the contribution of illegitimate recombination is extremely low. 
The following potential environmental implications are considered: 
1) Substitutive recombination between the CP4 epsps gene with natural variants, as they may 
occur in habitats receiving DNA of maize NK603 × T25, would only replace natural variants 
(substitutive recombination) and are therefore unlikely to provide any new property connected 
to a selective advantage for the recipient organisms (EFSA, 2009b). 
2) Double homologous recombination with terminator sequences of the nos gene would result in 
an insertion of the CP4 epsps gene into Ti plasmids and as a consequence confer resistance to 
glyphosate. CP4 EPSPS is already present in habitats receiving DNA of maize NK603 × T25 
and introduction of the CP4 epsps gene into A. tumefaciens would be unlikely to provide a 
selective advantage for the recipient organism. 
3) The pat gene could be transferred from DNA of NK603 × T25 by double homologous 
recombination onto pUC plasmids or other plasmids with corresponding sites of sequence 
identity. Alternatively, the pat gene could be transferred to bacterial strains with a capacity to 
recognise the ori within the recombinant gene cassette so that an independent replicating 
plasmid could be formed. Owing to the codon optimisation for expression in plant cells, it is, 
however, not expected that the pat gene would be as efficiently expressed as natural variants 
of similar genes occurring in bacteria. Even in the case of functionality and considering that 
pat genes originate from bacteria, e.g. S. viridochromogenes and other Actinobacteria, a 
transfer of the pat gene from NK603 × T25 would not confer a new trait to environmental 
bacterial communities. 
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Considering the intended uses (which exclude cultivation) of maize NK603 × T25, the EFSA GMO 
Panel concluded that the unlikely but theoretically possible horizontal gene transfer of recombinant 
genes from maize NK603 × T25 to bacteria does not give rise to any environmental safety concern. 
(b) Plant-to-plant gene transfer
36
 
Considering the scope of maize NK603 × T25 and the physical characteristics of maize grain, possible 
pathways of gene dispersal are (1) grain spillage during transport, and (2) processing and the dispersal 
of pollen from occasional feral GM maize plants originating from accidental grain spillage. 
The extent of cross-pollination to other maize varieties will mainly depend on the scale of accidental 
release during transport and processing, and on successful establishment and subsequent flowering of 
the GM maize plant. For maize, any vertical gene transfer is limited to other Zea mays plants, as 
populations of sexually compatible wild relatives of maize are not known in Europe (Eastham and 
Sweet, 2002; OECD, 2003). 
The flowering of occasional feral GM maize plants originating from accidental release during 
transport and processing is unlikely to disperse significant amounts of GM maize pollen to other maize 
plants. Field observations performed on maize volunteers after GM maize cultivation in Spain 
revealed that maize volunteers had a low vigour, rarely had cobs and produced pollen that cross-
pollinated neighbouring plants only at low levels (Palaudelmàs et al., 2009). 
Although GM maize plants outside cropped areas have been reported in Korea as a result of grain 
spillage during transport and processing (Kim et al., 2006; Lee et al., 2009; Park et al., 2010), survival 
of maize plants outside cultivation in Europe is mainly limited by a combination of low 
competitiveness, the absence of a dormancy phase, and susceptibility to plant pathogens, herbivores 
and frost. As for any other maize varieties, GM maize plants would only survive in subsequent seasons 
in warmer regions of Europe and are not likely to establish feral populations under European 
environmental conditions, even when treated with the intended herbicides. 
The EFSA GMO Panel takes into account the fact that this application does not include cultivation of 
maize NK603 × T25 within the EU, so that the likelihood of cross-pollination between cultivated 
maize and the occasional feral maize plants resulting from grain spillage is considered extremely low. 
In conclusion, considering the scope of maize NK603 × T25, the mode of action of the introduced 
traits, the outcomes of the molecular characterisation and of the comparative analysis, and the poor 
ability of maize to survive outside cultivated land, the EFSA GMO Panel is of the opinion that the 
likelihood of unintended environmental effects as a consequence of spread of genes from this GM 
maize in Europe will not differ from that of conventional maize varieties, even in the event of 
treatment with the intended herbicides. 
4.4.2.3. Potential interactions of the GM plant with target organisms37 
Interactions of maize NK603 × T25 with target organisms are not considered an issue by the EFSA 
GMO Panel, as there are no target organisms. 
4.4.2.4. Potential interactions of the GM plant with non-target organisms38 
Owing to the scope of maize NK603 × T25, which excludes cultivation, and the low level of exposure 
to the environment, potential interactions of the GM plant with non-target organisms were not 
considered an issue by the EFSA GMO Panel. 
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37 Dossier: Part I—Section D9.4. 
38 Dossier: Part I—Section D9.5. 
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4.4.2.5. Potential interactions with the abiotic environment and biogeochemical cycles39 
Considering the scope of maize NK603 × T25, which excludes cultivation, and the low level of 
exposure to the environment, potential interactions with the abiotic environment and biogeochemical 
cycles were not considered a relevant issue by the EFSA GMO Panel. 
4.4.3. Post-market environmental monitoring40 
The objectives of a post-market environmental monitoring (PMEM) plan according to Annex VII of 
Directive 2001/18/EC are (1) to confirm that any assumption regarding the occurrence and impact of 
potential adverse effects of the GMO, or its use, in the ERA are correct; and (2) to identify the 
occurrence of adverse effects of the GMO, or its use, on human health or the environment that were 
not anticipated in the ERA.  
Monitoring is also related to risk management, and thus a final adoption of the PMEM plan falls 
outside the mandate of the EFSA GMO Panel. However, the EFSA GMO Panel gives its opinion on 
the scientific quality of the PMEM plan provided by the applicants (EFSA GMO Panel, 2011b). 
The potential exposure to the environment of maize NK603 × T25 would be through ingestion by 
animals and their faecal material leading to exposure of the gastrointestinal tract and soil microbial 
populations to recombinant DNA, and through accidental release into the environment of viable 
NK603 × T25 seeds during transport and/or processing. As the ERA does not cover cultivation and no 
potential adverse effects have been identified, no case-specific monitoring is required. 
The PMEM plan proposed by the applicant includes (1) the description of an approach involving 
operators (federations involved in maize import and processing) reporting to the applicant, via a 
centralised system, any observed adverse effect(s) of GMOs on human health and the environment; 
(2) a coordinating system established by EuropaBio for the collection of information recorded by the 
various operators; and (3) the use of networks of existing surveillance systems (Lecoq et al., 2007; 
Windels et al., 2008). The applicant proposes to submit a PMEM report on an annual basis. 
The EFSA GMO Panel considers that the scope of the PMEM plan provided by the applicant is in line 
with the scope of maize NK603 × T25, as the ERA does not cover cultivation and no potential adverse 
effects have been identified. The EFSA GMO Panel agrees with the reporting intervals proposed by 
the applicant in its PMEM plans. 
4.4.4. Conclusion 
Considering the scope of maize NK603 × T25, the outcomes of the molecular characterisation and of 
the comparative analysis, and the poor ability of maize to survive outside cultivated land, the EFSA 
GMO Panel concludes that there are no indications that maize NK603 × T25 has an increased fitness 
potential compared with its conventional counterpart. Risks associated with an unlikely but 
theoretically possible horizontal gene transfer of recombinant DNA from maize NK603×T25 to 
bacteria have not been identified. Considering the scope of the GM maize, interactions with the biotic 
and abiotic environment are not considered to be a relevant issue. Therefore, the EFSA GMO Panel 
concludes that no safety concerns are expected in the event of the accidental release of viable GM 
maize grains into the environment. 
CONCLUSIONS AND RECOMMENDATIONS 
No new data on the single maize events NK603 and T25 that would lead to a modification of the 
original conclusions on their safety were identified. 
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40 Dossier: Part I—Section D11. 
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The combination of maize single events NK603 and T25 in the two-event stack maize NK603 × T25 
did not give rise to issues—relating to molecular, agronomic, phenotypic or compositional 
characteristics—regarding food and feed safety. The EFSA GMO Panel considers that there is no 
reason to expect interactions that could impact on the food and feed safety and nutritional properties. 
The compositional data indicate that maize NK603 × T25 would be expected to deliver the same 
nutrition as its non-GM comparator. 
Considering the scope of application EFSA-GMO-NL-2010-80, there are no indications of an 
increased likelihood of establishment and spread of feral maize NK603 × T25 plants in the case of 
accidental release into the environment of viable GM maize seeds. Potential interactions of maize 
NK603 × T25 with the biotic and abiotic environment were not considered a relevant issue by the 
EFSA GMO Panel. The unlikely but theoretically possible transfer of the recombinant genes from 
maize NK603 × T25 to environmental bacteria does not give rise to a safety concern owing to the lack 
of a selective advantage in the context of the scope of this application. The post-market environmental 
monitoring plan provided by the applicant and the reporting intervals are in line with the scope of 
application EFSA-GMO-NL-2010-80. 
In conclusion, the EFSA GMO Panel considers that the information available for maize NK603 × T25 
addresses the scientific comments raised by Member States and that maize NK603 × T25, as described 
in this application, is as safe as its non-GM comparator and non-GM conventional maize varieties with 
respect to potential effects on human and animal health and the environment in the context of its 
scope. 
DOCUMENTATION PROVIDED TO EFSA 
1. Letter from Competent Authority of the Netherlands received on 21 May 2010 concerning a 
request for authorisation for the placing on the market of maize NK603 × T25 (application EFSA-
GMO-NL-2010-80) submitted in accordance with Regulation (EC) No 1829/2003 by Monsanto 
Europe S.A./N.V. 
2. Acknowledgement letter dated 4 June 2010 from EFSA to the Competent Authority of the 
Netherlands. 
3. Letter from EFSA to applicant dated 2 July 2010 requesting additional information under 
completeness check.  
4. Letter from applicant to EFSA received on 1 September 2010 providing additional information 
under completeness check.  
5. Letter from applicant to EFSA received on 22 September 2010 providing additional information 
under completeness check.  
6. Letter from EFSA to applicant dated 12 October 2010 delivering the ‘Statement of Validity’ of 
application EFSA-GMO-NL-2010-80 (maize NK603 × T25) submitted by Monsanto Europe 
S.A./N.V under Regulation (EC) No 1829/2003. 
7. Letter from EFSA to applicant dated 16 December 2010 stopping the clock due to single event. 
8. Letter EFSA to applicant dated 23 September 2013 re-starting the clock due to single event. 
9. Letter from EFSA to applicant dated 16 December 2013 requesting additional information and 
stopping the clock. 
10. Letter from applicant to EFSA received on 3 February 2014 providing additional information. 
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11. Letter from EFSA to applicant dated 8 July 2014 requesting additional information and 
maintaining the clock stopped. 
12. Letter from applicant to EFSA received on 9 September 2014 providing additional information. 
13. Letter from EFSA to applicant dated 28 November 2014 requesting additional information and 
maintaining the clock stopped. 
14. Letter from applicant to EFSA received on 13 January 2015 providing additional information. 
15. Letter from EFSA to applicant dated 16 February 2015 requesting additional information and 
maintaining the clock stopped. 
16. Letter from EFSA to applicant dated 19 March 2015 requesting additional information and 
maintaining the clock stopped. 
17. Letter from applicant to EFSA received on 13 May 2015 providing additional information. 
18. Letter from applicant to EFSA received on 19 May 2015 providing additional information. 
19. Letter from applicant to EFSA received on 27 May 2015 providing complementary information to 
the additional information submitted. 
20. Letter from EFSA to applicant dated 23 June 2015 re-starting the clock. 
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